Concepedia

Naoki Takegawa

NT

Statistics

Publications

17

Citations

1.2K

H-Index

14

Active since

2000

Affiliations

Kindai University(Current)

SHOWA Medical University

Daiichi-Sankyo (Japan)

Kindai University Hospital

Hyogo Prefectural Cancer Center

Naoki Takegawa is an author at Kindai University specializing in oncology, medicine, and pharmacology.

Publications per year

2000–2023

17

Publications

17

DS‐8201a, a new HER2‐targeting antibody–drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2‐positive gastric cancer T‐DM1 resistance

Naoki Takegawa, Yoshikane Nonagase, Kimio Yonesaka et al. · International Journal of Cancer · 2017 · 195 citations · Full text

Medicine, Oncology, Pharmacology +17

A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, JCOG1109 NExT study.

Ken Kato, Yoshinori Ito, Hiroyuki Daiko et al. · Journal of Clinical Oncology · 2022 · 193 citations

Medicine, Oncology, Radiation Oncology +17

B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity

Kimio Yonesaka, Koji Haratani, Shiki Takamura et al. · Clinical Cancer Research · 2018 · 169 citations

Medicine, Immunology, Oncology +17

An HER3-targeting antibody–drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC

Kimio Yonesaka, Naoki Takegawa, Satomi Watanabe et al. · Oncogene · 2018 · 101 citations

Medicine, Oncology, Pharmacology +14

Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors

Masayuki Takeda, Takayuki Takahama, Kazuko Sakai et al. · The Oncologist · 2020 · 95 citations · Full text

Medicine, Molecular Medicine, Oncology +17

1–5 of 17